![Tai Wah Chan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tai Wah Chan has been Vice President of Pharmaceutical Research and Development for DURECT Corp.
since August 2001.
He was an Executive Director of Pharmaceutical Research for DURECT from February 2000 to August 2001 and Senior Director of Pharmaceutical Research from November 1999 to February 2000.
Dr. Chan was a Senior Scientist of Oread, Inc. from October 1996 to October 1997.
He received a BS degree in Physics and Chemistry from the University of Hong Kong and a PhD in Chemistry from the University of Chicago.
| Sociétés | Poste | Fin |
|---|---|---|
Oread, Inc.
 Oread, Inc. Pharmaceuticals: MajorHealth Technology Operates a drug development and manufacturing operations | Directeur Technique/Scientifique/R&D | 01/11/1998 |
| DURECT | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
DURECT Corp.
 DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases | Health Technology |
Oread, Inc.
Oread, Inc. Pharmaceuticals: MajorHealth Technology Operates a drug development and manufacturing operations | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
